Cite
HARVARD Citation
Navid, F. et al. (n.d.). A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy. International journal of cancer. 141 (7), pp. 1469-1477. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Navid, F. et al. (n.d.). A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy. International journal of cancer. 141 (7), pp. 1469-1477. [Online].